Medicine and Dentistry
Prevalence
99%
Disease
88%
Biological Marker
86%
COVID-19
71%
Parkinson's Disease
69%
Infection
69%
Clinical Trial
65%
Diabetes
63%
Meta-Analysis
47%
Physical Activity
47%
microRNA
46%
Cohort Analysis
44%
Systematic Review
44%
Randomized Controlled Trial
42%
Public Health
42%
Arm
42%
Medicine
41%
Cardiovascular Disease
37%
Malignant Neoplasm
37%
Medical Examination
37%
Cross Sectional Study
35%
Neoplasm
34%
Oncology
34%
Body Mass Index
33%
Melanoma
33%
Quality of Life
32%
Cardiovascular System
31%
Gene Expression
31%
Chagas Disease
31%
Ganglioglioma
31%
Odds Ratio
30%
Acute Heart Infarction
30%
Pooled Analysis
30%
Microglia
29%
Arteriosclerosis
29%
Population
28%
Personalized Medicine
28%
Drug Megadose
28%
Heart Arrest
26%
Cardiovascular Risk
26%
Human Immunodeficiency Virus
26%
Chemotherapy
26%
Ivermectin
25%
Observational Study
25%
Diagnosis
25%
Glioblastoma
25%
Radiation Therapy
24%
Congestive Heart Failure
23%
Obesity
23%
Myocardial Infarction
23%
Cohort Effect
23%
Adverse Event
23%
Acute Myeloid Leukemia
22%
Diet Quality
22%
Red Wine
22%
Benzodiazepine
22%
Lifestyle Modification
22%
Insulin Dependent Diabetes Mellitus
22%
Health Care Cost
21%
Placebo
20%
Hemoglobin A1c
20%
Progression Free Survival
20%
Immunity
20%
Combination Therapy
20%
Single Drug Dose
19%
Cardiometabolic Risk
19%
Schistosomiasis
19%
Xenograft
19%
Severe Acute Respiratory Syndrome Coronavirus 2
18%
Clinical Trial Design
18%
Comorbidity
18%
Onchocerciasis
18%
Randomized Clinical Trial
17%
Helminth
17%
Moxidectin
17%
Adolescence
16%
Disease Severity
16%
Gut Microbiome
16%
Drug Therapy
16%
Clinical Research
15%
Circulating microRNA
15%
Impaired Glucose Tolerance
15%
Benznidazole
15%
Cytarabine
15%
Low and Middle Income Countries
15%
Albendazole
15%
Drug Response
15%
Health Outcomes
15%
Fexinidazole
15%
Smoking
15%
Onchocerca volvulus
15%
Frailty
15%
Lipopolysaccharide-Induced Inflammation
14%
Mild Cognitive Impairment
14%
Out of Hospital Cardiac Arrest
14%
Prostate Cancer
14%
Drug Screening
14%
Neglected Tropical Diseases
14%
Network Meta-Analysis
14%
Macrophage
14%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
92%
Clinical Trial
88%
Parkinson's Disease
88%
Prevalence
83%
Biological Marker
64%
Infection
52%
Adverse Event
49%
Randomized Controlled Trial
46%
microRNA
40%
Drug Development
38%
Combination Therapy
38%
Malignant Neoplasm
37%
Artesunate
37%
Acute Heart Infarction
36%
Placebo
33%
Schistosomiasis
32%
HIV
31%
Chagas Disease
30%
Amodiaquine
30%
Multiple Chronic Conditions
29%
Out of Hospital Cardiac Arrest
29%
Pharmacokinetics
28%
Antimalarial Agent
28%
Monotherapy
27%
Heart Infarction
27%
Observational Study
26%
Praziquantel
26%
Ivermectin
25%
Cardiovascular Disease
25%
Cross-Sectional Study
24%
Glioblastoma
23%
Elimination
22%
Benzodiazepine
22%
Hospital Mortality
22%
Melanoma
22%
Congestive Heart Failure
21%
Normal Human
19%
Ethanol
19%
Artemisinin
19%
Obesity
18%
Hair Analysis
18%
Tablet
18%
Heart Ventricle Remodeling
18%
Progression Free Survival
17%
Neuron Specific Enolase
17%
Heart Arrest
17%
Cohort Study
17%
Chemotherapy
17%
Comorbidity
16%
Cardiovascular Risk
15%
Long Untranslated RNA
15%
Benznidazole
15%
Albendazole
15%
Helminth
15%
Headache
15%
Base
15%
Hemoglobin A1c
15%
Drug Resistance
15%
Lassa Fever
14%
Chronic Pain
14%
Levodopa-Induced Dyskinesia
14%
Carotid Atherosclerosis
14%
Arteriosclerosis
14%
Sustained Release
14%
Flucytosine
14%
Bioavailability
14%
Onchocerca volvulus
14%
Fexinidazole
14%
Microfilaria (Nematode Larva)
14%
Prostate Cancer
14%
Clinical Trial Design
14%
Moxidectin
14%
Neoplasm
14%
RNA-Sequencing
13%
Combination Drug
13%
Health Status
13%
Rare Disease
13%
Clinical Feature
13%
Schistosoma
12%
Randomized Clinical Trial
12%
Overall Survival
12%
Drug Safety
12%
Malaria Falciparum
11%
Circulating microRNA
11%
Knockout Mouse
11%
Intestine Volvulus
11%
Hypnotic
11%
Lipopolysaccharide
11%
Cross Sectional Study
11%
Long Term Exposure
11%
Phase II Trials
10%
SARS Coronavirus
10%
Environmental Exposure
10%
Syndrome
9%
Anemia
9%
Group Trial
9%
Exposure Assessment
9%
Antihypertensive Agent
9%
Multiple Myeloma
9%
microRNA 124
9%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
Prevalence
49%
Transcriptomics
49%
Microarrays
47%
Myeloid
42%
Gene Expression
41%
Microglia
36%
Cohort Study
36%
Clinical Trial
34%
RNA
34%
Transcriptome
34%
Cardiac Arrest
29%
SARS Coronavirus
29%
Population
28%
Gene Expression Profiling
26%
Long Non-Coding RNA
26%
Physical Activity
26%
Mouse Model
25%
Zebra Fish
25%
Biological Phenomena and Functions Concerning the Entire Organism
24%
Immunity
24%
Protein Interaction
22%
Interactome
22%
Endothelial Progenitor Cell
22%
Tamsulosin
22%
Drug Response
20%
RNA Sequence
20%
Genomics
19%
Genetics
18%
Dopaminergic
18%
Randomized Controlled Trial
18%
Dendritic Cell
18%
Medline
18%
Gene Expression Data
18%
Secretion (Process)
17%
Molecular Network
17%
Promoter Region
16%
Proteomics
16%
Smoking
16%
Comorbidity
16%
Targeted Temperature Management
15%
Support Vector Machine
15%
Glucose Blood Level
15%
Long Noncoding RNA
14%
T Cell
14%
PARK7
14%
Randomized Clinical Trial
14%
Phagocyte
14%
Alternative Splicing
14%
Autophagy
14%
Cell Migration
14%
Lipopolysaccharide
14%
Stem Cell
14%
Cell Proliferation
14%
Heart Left Ventricle Function
14%
Messenger RNA
13%
Signal Transduction
12%
Carcinogenesis
12%
Macrophage
12%
Cell Cycle
12%
Interferon
12%
Metabolic Pathway
12%
Blood Level
12%
Transcription Factors
12%
Interleukin 6
12%
Interleukin 8
12%
Cancer Cell
11%
Health Status
11%
Body Mass
11%
Immune Response
11%
Artificial Intelligence
11%
Prospective Cohort Study
11%
Audio Recording
11%
Genetic Transcription
11%
Transcription
10%
Epigenetics
10%
Vascularization
10%
Adenosine
10%
Heart Ventricle Function
10%
Reprogramming
10%
Enolase
10%
Blood Pressure
10%
Solution and Solubility
9%
Population Research
9%
Cell Growth
9%
Cyclin-Dependent Kinase
9%
Cholesterol Blood Level
9%
Normal Human
9%
Drug Sensitivity
9%
Circular RNA
9%
Epidermal Growth Factor Receptor
9%
Medical Biology
9%
K Nearest Neighbor
9%
Patient Coding
8%
Aerobic Metabolism
8%
Immunocompetent Cell
8%
Oncogene
8%
Platelet-Derived Growth Factor Receptor
8%
Progression Free Survival
8%
Metabolite
8%